Open Access

Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes

  • Authors:
    • Shi-Tao Zhao
    • Zhi-Cong Qiu
    • Rui-Yuan Zeng
    • Hua-Xi Zou
    • Rong-Bin Qiu
    • Han-Zhi Peng
    • Lian-Fen Zhou
    • Zhi-Qiang Xu
    • Song-Qing Lai
    • Li Wan
  • View Affiliations

  • Published online on: March 22, 2024     https://doi.org/10.3892/etm.2024.12509
  • Article Number: 221
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ischemic cardiomyopathy (ICM) is a serious cardiac disease with a very high mortality rate worldwide, which causes myocardial ischemia and hypoxia as the main damage. Further understanding of the underlying pathological processes of cardiomyocyte injury is key to the development of cardioprotective strategies. Ferroptosis is an iron‑dependent form of regulated cell death characterized by the accumulation of lipid hydroperoxides to lethal levels, resulting in oxidative damage to the cell membrane. The current understanding of the role and regulation of ferroptosis in ICM is still limited, especially in the absence of evidence from large‑scale transcriptomic data. Through comprehensive bioinformatics analysis of human ICM transcriptome data obtained from the Gene Expression Omnibus database, the present study identified differentially expressed ferroptosis‑related genes (DEFRGs) in ICM. Subsequently, their potential biological mechanisms and cross‑talk were analyzed, and hub genes were identified by constructing protein‑protein interaction networks. Ferroptosis features such as reactive oxygen species generation, changes in ferroptosis marker proteins, iron ion aggregation and lipid oxidation, were identified in the H9c2 anoxic reoxygenation injury model. Finally, the diagnostic ability of Gap junction alpha‑1 (GJA1), Solute carrier family 40 member 1 (SLC40A1), Alpha‑synuclein (SNCA) were identified through receiver operating characteristic curves and the expression of DEFRGs was verified in an in vitro model. Furthermore, potential drugs (retinoic acid) that could regulate ICM ferroptosis were predicted based on key DEFRGs. The present article presents new insights into the role of ferroptosis in ICM, investigating the regulatory role of ferroptosis in the pathological process of ICM and advocating for ferroptosis as a potential novel therapeutic target for ICM based on evidence from the ICM transcriptome.
View Figures
View References

Related Articles

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao S, Qiu Z, Zeng R, Zou H, Qiu R, Peng H, Zhou L, Xu Z, Lai S, Wan L, Wan L, et al: Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes. Exp Ther Med 27: 221, 2024
APA
Zhao, S., Qiu, Z., Zeng, R., Zou, H., Qiu, R., Peng, H. ... Wan, L. (2024). Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes. Experimental and Therapeutic Medicine, 27, 221. https://doi.org/10.3892/etm.2024.12509
MLA
Zhao, S., Qiu, Z., Zeng, R., Zou, H., Qiu, R., Peng, H., Zhou, L., Xu, Z., Lai, S., Wan, L."Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes". Experimental and Therapeutic Medicine 27.5 (2024): 221.
Chicago
Zhao, S., Qiu, Z., Zeng, R., Zou, H., Qiu, R., Peng, H., Zhou, L., Xu, Z., Lai, S., Wan, L."Exploring the molecular biology of ischemic cardiomyopathy based on ferroptosis‑related genes". Experimental and Therapeutic Medicine 27, no. 5 (2024): 221. https://doi.org/10.3892/etm.2024.12509